These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 22525513)
1. Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertension. Morecroft I; White K; Caruso P; Nilsen M; Loughlin L; Alba R; Reynolds PN; Danilov SM; Baker AH; Maclean MR Mol Ther; 2012 Aug; 20(8):1516-28. PubMed ID: 22525513 [TBL] [Abstract][Full Text] [Related]
2. Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression. Ciuclan L; Hussey MJ; Burton V; Good R; Duggan N; Beach S; Jones P; Fox R; Clay I; Bonneau O; Konstantinova I; Pearce A; Rowlands DJ; Jarai G; Westwick J; MacLean MR; Thomas M Am J Respir Crit Care Med; 2013 Jan; 187(1):78-89. PubMed ID: 23087024 [TBL] [Abstract][Full Text] [Related]
3. Serotonin passes through myoendothelial gap junctions to promote pulmonary arterial smooth muscle cell differentiation. Gairhe S; Bauer NN; Gebb SA; McMurtry IF Am J Physiol Lung Cell Mol Physiol; 2012 Nov; 303(9):L767-77. PubMed ID: 22923644 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia does neither stimulate pulmonary artery endothelial cell proliferation in mice and rats with pulmonary hypertension and vascular remodeling nor in human pulmonary artery endothelial cells. Yu L; Hales CA J Vasc Res; 2011; 48(6):465-75. PubMed ID: 21691120 [TBL] [Abstract][Full Text] [Related]
5. Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension. Aiello RJ; Bourassa PA; Zhang Q; Dubins J; Goldberg DR; De Lombaert S; Humbert M; Guignabert C; Cavasin MA; McKinsey TA; Paralkar V J Pharmacol Exp Ther; 2017 Feb; 360(2):267-279. PubMed ID: 27927914 [TBL] [Abstract][Full Text] [Related]
6. Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension. Dempsie Y; MacRitchie NA; White K; Morecroft I; Wright AF; Nilsen M; Loughlin L; Mair KM; MacLean MR Cardiovasc Res; 2013 Jul; 99(1):24-34. PubMed ID: 23519266 [TBL] [Abstract][Full Text] [Related]
7. TRPC4 aggravates hypoxic pulmonary hypertension by promoting pulmonary endothelial cell apoptosis. Yang L; Peng Z; Gong F; Yan W; Shi Y; Li H; Zhou C; Yao H; Yuan M; Yu F; Feng L; Wan N; Liu G Free Radic Biol Med; 2024 Jul; 219():141-152. PubMed ID: 38636714 [TBL] [Abstract][Full Text] [Related]
8. Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension. Zhang Q; Yaoita N; Tabuchi A; Liu S; Chen SH; Li Q; Hegemann N; Li C; Rodor J; Timm S; Laban H; Finkel T; Stevens T; Alvarez DF; Erfinanda L; de Perrot M; Kucherenko MM; Knosalla C; Ochs M; Dimmeler S; Korff T; Verma S; Baker AH; Kuebler WM Circulation; 2024 Aug; 150(6):466-487. PubMed ID: 38873770 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of Hsp110-STAT3 interaction in endothelial cells alleviates vascular remodeling in hypoxic pulmonary arterial Hypertension model. Zhao C; Le X; Li M; Hu Y; Li X; Chen Z; Hu G; Hu L; Li Q Respir Res; 2023 Nov; 24(1):289. PubMed ID: 37978368 [TBL] [Abstract][Full Text] [Related]
10. The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension. White K; Dempsie Y; Nilsen M; Wright AF; Loughlin L; MacLean MR Cardiovasc Res; 2011 May; 90(2):373-82. PubMed ID: 21177701 [TBL] [Abstract][Full Text] [Related]
12. Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice. Izikki M; Hanoun N; Marcos E; Savale L; Barlier-Mur AM; Saurini F; Eddahibi S; Hamon M; Adnot S Am J Physiol Lung Cell Mol Physiol; 2007 Oct; 293(4):L1045-52. PubMed ID: 17675372 [TBL] [Abstract][Full Text] [Related]
13. Serotonin and pulmonary hypertension--from bench to bedside? MacLean MR; Dempsie Y Curr Opin Pharmacol; 2009 Jun; 9(3):281-6. PubMed ID: 19286424 [TBL] [Abstract][Full Text] [Related]
14. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation. Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556 [TBL] [Abstract][Full Text] [Related]
15. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice. Huh JW; Kim SY; Lee JH; Lee YS Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997 [TBL] [Abstract][Full Text] [Related]
16. IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial Cells. Liu J; Wang W; Wang L; Chen S; Tian B; Huang K; Corrigan CJ; Ying S; Wang W; Wang C EBioMedicine; 2018 Jul; 33():196-210. PubMed ID: 29921553 [TBL] [Abstract][Full Text] [Related]
17. MMP-2 and MMP-9 contribute to the angiogenic effect produced by hypoxia/15-HETE in pulmonary endothelial cells. Liu Y; Zhang H; Yan L; Du W; Zhang M; Chen H; Zhang L; Li G; Li J; Dong Y; Zhu D J Mol Cell Cardiol; 2018 Aug; 121():36-50. PubMed ID: 29913136 [TBL] [Abstract][Full Text] [Related]
18. Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling. Kang BY; Park KK; Kleinhenz JM; Murphy TC; Green DE; Bijli KM; Yeligar SM; Carthan KA; Searles CD; Sutliff RL; Hart CM Am J Respir Cell Mol Biol; 2016 Jan; 54(1):136-46. PubMed ID: 26098770 [TBL] [Abstract][Full Text] [Related]
19. Established pulmonary hypertension in rats was reversed by a combination of a HIF-2α antagonist and a p53 agonist. Zheng Q; Lu W; Yan H; Duan X; Chen Y; Zhang C; Luo X; Chen J; Wang C; Liu S; Li Y; Tang H; Rahimi S; Rahimi S; Yuan JX; Zhong N; Yang K; Wang J Br J Pharmacol; 2022 Mar; 179(5):1065-1081. PubMed ID: 34599843 [TBL] [Abstract][Full Text] [Related]